- Report
- December 2023
- 351 Pages
Global
From €4130EUR$4,297USD£3,542GBP
- Report
- November 2023
- 337 Pages
Global
From €4767EUR$5,134USD£3,950GBP
- Report
- September 2023
- 310 Pages
Global
From €4767EUR$5,134USD£3,950GBP
- Report
- March 2024
- 184 Pages
Global
From €3243EUR$3,374USD£2,781GBP
€3603EUR$3,749USD£3,090GBP
- Report
- June 2023
- 180 Pages
Global
From €5719EUR$5,950USD£4,904GBP
- Report
- May 2024
- 289 Pages
Global
From €4758EUR$4,950USD£4,080GBP
- Report
- May 2024
- 193 Pages
Global
From €5238EUR$5,450USD£4,492GBP
- Report
- May 2024
- 202 Pages
Global
From €5382EUR$5,600USD£4,616GBP
- Report
- May 2024
- 369 Pages
Global
From €5382EUR$5,600USD£4,616GBP
- Report
- January 2024
- 200 Pages
Global
From €4806EUR$5,000USD£4,121GBP
- Report
- February 2024
- 175 Pages
Global
From €4806EUR$5,000USD£4,121GBP
- Report
- February 2024
- 175 Pages
Global
From €4806EUR$5,000USD£4,121GBP
- Report
- November 2023
- 175 Pages
Global
From €4806EUR$5,000USD£4,121GBP
- Report
- April 2024
- 135 Pages
Global
From €3748EUR$3,899USD£3,214GBP
- Report
- October 2023
- 172 Pages
Global
From €4710EUR$4,900USD£4,039GBP
- Report
- October 2023
- 172 Pages
Global
From €4710EUR$4,900USD£4,039GBP
- Report
- October 2023
- 175 Pages
Global
From €4710EUR$4,900USD£4,039GBP
- Report
- September 2023
- 190 Pages
Global
From €4710EUR$4,900USD£4,039GBP
- Report
- October 2023
- 156 Pages
Global
From €2403EUR$2,500USD£2,061GBP
- Report
- August 2023
- 175 Pages
Global
From €3061EUR$3,185USD£2,625GBP
€4373EUR$4,550USD£3,750GBP
The Adult Stem Cell market is a subset of the larger Stem Cell market, which is focused on the use of stem cells for medical treatments. Adult stem cells are found in the body and are used to replace or repair damaged tissue. These cells can be harvested from a patient's own body, or from a donor, and then used to treat a variety of conditions, including cancer, heart disease, and neurological disorders.
The Adult Stem Cell market is driven by the increasing demand for stem cell therapies, as well as the development of new technologies and techniques for harvesting and processing stem cells. Additionally, the market is supported by government funding and private investments.
Companies in the Adult Stem Cell market include Celgene Corporation, Osiris Therapeutics, Inc., Athersys, Inc., and Mesoblast Limited. Show Less Read more